Cell cycle regulators: mechanisms and their role in aetiology, prognosis, and treatment of cancer.
about
Biological background of pediatric medulloblastoma and ependymoma: a review from a translational research perspectiveExpression of transforming growth factor-beta-1 and p27Kip1 in pancreatic adenocarcinomas: relation with cell-cycle-associated proteins and clinicopathologic characteristicsp21(waf) correlates with DNA replication but not with prognosis in invasive breast cancerInduction of apoptosis by d-limonene is mediated by a caspase-dependent mitochondrial death pathway in human leukemia cells.P53 expression is significantly correlated with high risk of malignancy and epithelioid differentiation in GISTs. An immunohistochemical study of 104 cases.Alpha-santalol, a chemopreventive agent against skin cancer, causes G2/M cell cycle arrest in both p53-mutated human epidermoid carcinoma A431 cells and p53 wild-type human melanoma UACC-62 cells.Correlation of cell cycle regulatory proteins (p53 and p16(ink)⁴(a)) and bcl-2 oncoprotein with mitotic index and thickness of primary cutaneous malignant melanomaColorectal neoplasia in ulcerative colitis-recent advances.Antineoplastic effects of α-santalol on estrogen receptor-positive and estrogen receptor-negative breast cancer cells through cell cycle arrest at G2/M phase and induction of apoptosis.Defects in G1-S cell cycle control in head and neck cancer: a review.Cyclin D1 overexpression is associated with poor clinicopathological outcome and survival in oral squamous cell carcinoma in Asian populations: insights from a meta-analysisInhibition of cell growth and induction of apoptosis in ovarian carcinoma cell lines CaOV3 and SKOV3 by natural withanolide Withaferin AImmunohistochemical expression of p16, p21, p27 and cyclin D1 in oral nevi and melanoma.Cyclin A is a prognostic indicator in early stage breast cancer with and without tamoxifen treatment.Cell cycle control as a basis for cancer chemoprevention through dietary agents.Honokiol, a chemopreventive agent against skin cancer, induces cell cycle arrest and apoptosis in human epidermoid A431 cells.Comparison of the inhibitory effects of three transcriptional variants of CDKN2A in human lung cancer cell line A549.A C 21 -Steroidal Glycoside Isolated from the Roots of Cynanchum auriculatum Induces Cell Cycle Arrest and Apoptosis in Human Gastric Cancer SGC-7901 Cells.Cyclin D1 overexpression in colorectal carcinoma in vivo is dependent on beta-catenin protein dysregulation, but not k-ras mutation.Chemoprevention of Breast Cancer by Transdermal Delivery of α-Santalol through Breast Skin and Mammary Papilla (Nipple).The prognostic implication of the expression of EGFR, p53, cyclin D1, Bcl-2 and p16 in primary locally advanced oral squamous cell carcinoma cases: a tissue microarray study.Tetramethylpyrazine inhibits angiotensin II-induced activation of hepatic stellate cells associated with interference of platelet-derived growth factor β receptor pathways.α-Santalol, a skin cancer chemopreventive agent with potential to target various pathways involved in photocarcinogenesis.Role of immunohistochemical markers in predicting progression of dysplasia to advanced neoplasia in patients with ulcerative colitis.Chemoprevention studies of the flavonoids quercetin and rutin in normal and azoxymethane-treated mouse colon.Cyclin Dl expression in B-cell non Hodgkin lymphoma.Cyclin D1, p16(INK) (4A) and p27(Kip1) in pancreatic adenocarcinoma: assessing prognostic implications through quantitative image analysis.
P2860
Q24658389-B44CB538-740D-48F7-AAD8-C3838A58D1ADQ24813147-C132AEF5-C4DA-4698-B5B9-1C79E0EFD4E3Q28362835-09E0F5BA-F604-4033-97CE-3AE0B1BA860CQ33266642-9889E970-D554-46D6-A657-4057C9AA74A0Q33354638-A248779E-4A37-480D-AF46-F8FD4FA1FB0AQ33648548-0B2B9A65-40B3-434C-B9EB-AF199A37BE1EQ33847911-FDB886B7-9D9D-43E9-AE08-1D88F5F74641Q34352889-F1549E7D-0FF3-44E9-9369-53ED8FDE2632Q34602854-CA1FB0E1-3F34-42C9-9976-CDE2BF084D72Q34733424-297749D9-5390-45DB-B26A-5B7486040429Q35133444-3225B3B9-B402-47A9-9A3C-6B65B9C13128Q35754252-E2AE2A37-13D7-4A36-BE97-5842C2B6F254Q36174359-1ADB8691-80F7-42A3-84A2-BDB69D3F4DAEQ36643848-B606816A-E8E5-4909-8876-C3559FE7CAA8Q36663023-4A6B0CA7-17E5-4F9A-ADAD-723E63ADD17CQ39476105-53677E03-F9EF-45C0-A85B-71FA2D2FD38CQ39690220-ACF52AF7-B98A-4E4F-AAAD-6F15F3FE8206Q41850512-D9E561B4-3ABC-4760-9691-A0B27E75D3DEQ44039327-8AF192D3-CF49-4D9E-94D7-F591E843D81DQ46338448-1BA75855-D87B-4122-BB50-77BAB66D348AQ51342055-875357B7-3E49-43D0-A889-D0F08422C377Q53058328-F627A6A9-2CD7-44A1-8577-23ECD3EE9399Q53116919-57687199-C013-4E57-A0A5-F99E97D7B8ABQ53287731-E984EBEF-F634-47B0-9D4C-CE5174DFA073Q53406369-A4C09EFB-C950-4EDC-A150-7D7B67DDA716Q53543241-DBC42FE4-4F8F-42EA-8CBA-2096E4BE5B18Q54335649-87CBB918-34FE-4B46-83A2-FD7A1A7D88CB
P2860
Cell cycle regulators: mechanisms and their role in aetiology, prognosis, and treatment of cancer.
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Cell cycle regulators: mechani ...... osis, and treatment of cancer.
@ast
Cell cycle regulators: mechani ...... osis, and treatment of cancer.
@en
type
label
Cell cycle regulators: mechani ...... osis, and treatment of cancer.
@ast
Cell cycle regulators: mechani ...... osis, and treatment of cancer.
@en
prefLabel
Cell cycle regulators: mechani ...... osis, and treatment of cancer.
@ast
Cell cycle regulators: mechani ...... osis, and treatment of cancer.
@en
P2860
P356
P1476
Cell cycle regulators: mechani ...... osis, and treatment of cancer.
@en
P2093
Michalides RJ
P2860
P304
P356
10.1136/JCP.52.8.555
P407
P577
1999-08-01T00:00:00Z